These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8385976)

  • 1. Effect of polyunsaturated fatty acids on the drug sensitivity of human tumour cell lines resistant to either cisplatin or doxorubicin.
    Plumb JA; Luo W; Kerr DJ
    Br J Cancer; 1993 Apr; 67(4):728-33. PubMed ID: 8385976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a new antioestrogen, idoxifene, on cisplatin- and doxorubicin-sensitive and -resistant human ovarian carcinoma cell lines.
    Sharp SY; Rowlands MG; Jarman M; Kelland LR
    Br J Cancer; 1994 Sep; 70(3):409-14. PubMed ID: 8080723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can tumour cell drug resistance be reversed by essential fatty acids and their metabolites?
    Das UN; Madhavi N; Sravan Kumar G; Padma M; Sangeetha P
    Prostaglandins Leukot Essent Fatty Acids; 1998 Jan; 58(1):39-54. PubMed ID: 9482165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential sensitivity of tumorigenic and genetically related non-tumorigenic cells to cytotoxic polyunsaturated fatty acids.
    Bégin ME; Sircar S; Weber JM
    Anticancer Res; 1989; 9(4):1049-52. PubMed ID: 2554786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression and hyperactivity of breast cancer-associated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal alpha-linolenic and gamma-linolenic fatty acids: a novel mechanism by which dietary fat can alter mammary tumorigenesis.
    Menendez JA; Ropero S; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Jun; 24(6):1369-83. PubMed ID: 15138577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bendamustine hydrochloride activity against doxorubicin-resistant human breast carcinoma cell lines.
    Strumberg D; Harstrick A; Doll K; Hoffmann B; Seeber S
    Anticancer Drugs; 1996 Jun; 7(4):415-21. PubMed ID: 8826610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human ovarian cancer cell lines resistant to cisplatin, doxorubicin, and L-phenylalanine mustard are sensitive to delta 7-prostaglandin A1 and delta 12-prostaglandin J2.
    Sasaki H; Takada K; Terashima Y; Ekimoto H; Takahashi K; Tsuruo T; Fukushima M
    Gynecol Oncol; 1991 Apr; 41(1):36-40. PubMed ID: 2026357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transformation renders MDR cells more sensitive to polyunsaturated fatty acids.
    Sircar S; Cai F; Begin ME; Weber JM
    Anticancer Res; 1990; 10(6):1783-6. PubMed ID: 2178327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of fatty acids and analogues upon intracellular levels of doxorubicin in cells displaying P-glycoprotein mediated multidrug resistance.
    Abulrob AN; Mason M; Bryce R; Gumbleton M
    J Drug Target; 2000; 8(4):247-56. PubMed ID: 11144235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective killing of human cancer cells by polyunsaturated fatty acids.
    Bégin ME; Das UN; Ells G; Horrobin DF
    Prostaglandins Leukot Med; 1985 Aug; 19(2):177-86. PubMed ID: 2864701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipids in breast carcinogenesis.
    Pritchard GA; Jones DL; Mansel RE
    Br J Surg; 1989 Oct; 76(10):1069-73. PubMed ID: 2557113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifactorial mechanisms associated with broad cross-resistance of ovarian carcinoma cells selected by cyanomorpholino doxorubicin.
    Lau DH; Lewis AD; Ehsan MN; Sikic BI
    Cancer Res; 1991 Oct; 51(19):5181-7. PubMed ID: 1717140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of n-3 and n-6 polyunsaturated fatty acids on BRCA1 and BRCA2 gene expression in breast cell lines.
    Bernard-Gallon DJ; Vissac-Sabatier C; Antoine-Vincent D; Rio PG; Maurizis JC; Fustier P; Bignon YJ
    Br J Nutr; 2002 Apr; 87(4):281-9. PubMed ID: 12064337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-resistance and collateral sensitivity to natural product drugs in cisplatin-sensitive and -resistant rat lymphoma and human ovarian carcinoma cells.
    Parekh H; Simpkins H
    Cancer Chemother Pharmacol; 1996; 37(5):457-62. PubMed ID: 8599869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of eicosapentaenoic acid, gamma-linolenic acid and prostaglandin E1 on three human colon carcinoma cell lines.
    Mengeaud V; Nano JL; Fournel S; Rampal P
    Prostaglandins Leukot Essent Fatty Acids; 1992 Dec; 47(4):313-9. PubMed ID: 1337209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of drug resistance in human breast and ovarian cancers.
    Kern DH
    Cancer J Sci Am; 1998; 4(1):41-5. PubMed ID: 9467045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of ifosfamide, dacarbazine, doxorubicin and cisplatin in human sarcoma xenografts.
    Budach W; Budach V; Stuschke M; Schmauder B; Reipke P; Scheulen ME
    Br J Cancer; 1994 Jul; 70(1):29-34. PubMed ID: 8018537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of thaliblastine on cytotoxicity and DNA damage in drug-sensitive and -resistant rat ovarian tumor cells treated with cisplatin.
    Chen G; Zeller WJ
    Anticancer Res; 1993; 13(1):219-23. PubMed ID: 8476216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omega-6 polyunsaturated fatty acid gamma-linolenic acid (18:3n-6) enhances docetaxel (Taxotere) cytotoxicity in human breast carcinoma cells: Relationship to lipid peroxidation and HER-2/neu expression.
    Menendez JA; Ropero S; Lupu R; Colomer R
    Oncol Rep; 2004 Jun; 11(6):1241-52. PubMed ID: 15138562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. n-3 fatty acids of marine origin lower systolic blood pressure and triglycerides but raise LDL cholesterol compared with n-3 and n-6 fatty acids from plants.
    Kestin M; Clifton P; Belling GB; Nestel PJ
    Am J Clin Nutr; 1990 Jun; 51(6):1028-34. PubMed ID: 1971991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.